Clinical features and epidemiology of severe cutanous adverse drug reactions;Schwere arzneimittelreaktionen der haut: Klinik und epidemiologie

Hautarzt

Volumn 56, Issue 1, 2005, Pages 24-31

  Mockenhaupt, M ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Acute generalized exanthematous pustulosis (AGEP); Mortality; Severe cutaneous adverse drug reactions; Stevens Johnson syndrome (SJS); Toxic epidermal necrolysis (TEN)

Indexed keywords

DRUG;

ADVERSE DRUG REACTION; CLINICAL FEATURE; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; HISTOLOGY; HUMAN; MORTALITY; PUSTULOSIS; REVIEW; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

EID: 13644266910     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00105-004-0874-5     Document Type: Review

References (33)

1. Assier H, Bastuji-Garin S, Revuz J, Roujeau JC (1995) Erythema multiforme with mucous membrane involvement and Stevens-Johnson syndrome are clinically different disorders with distinct causes. Arch Dermatol 131:539-543
2. Auquier-Dunant A, Mockenhaupt M, Naldi L et al. (2002) Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis. Arch Dermatol 138:1019-1024
3. Bastuji-Garin S, Fouchard N, Bertocchi M et al. (2000) SCORTEN: a severity-of-illness score for toxic epidermal necrolysis. J Invest Dermatol 115:149-153
4. Bastuji-Garin S, Rzany B, Stern RS et al. (1993) Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 129:92-96
5. Beylot C, Bioulac P, Doutre MS (1980) Acute generalized exanthematic pustuloses (four cases, author's transl.). Ann Dermatol Venereol 146:283
6. Bocquet H, Bagot M, Rojeau JC (1996) Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS). Semin Cutan Med Surg 15:250-257
7. Elias PM, Fritsch P, Epstein EH Jr (1977) Staphylococcal scalded skin syndrome: clinical features, pathogenesis, and recent microbiological and biochemical developments. Arch Dermatol 113:207
8. Fagot JP, Mockenhaupt M, Bouwes Bavinck JN et al. (2001) Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis - preliminary results of a case-control study. AIDS 15:1-6
9. Fournier S, Bastuji-Garin S, Mentec H et al. (1995) Toxic epidermal necrolysis associated with mycoplasma pneumoniae infection. Eur J Clin Microbiol Infect Dis 14:558-559
10. Hebra F von (1866) Erythema exsudativum multiforme. In: Atlas der Hautkrankheiten. Kaiserliche Akademie der Wissenschaften, Wien, S 54-57
11. Kauppinen K (1972) Cutaneous reactions to drugs. With special reference to severe bullous mucocutaneous eruptions and sulphonamides. A clinical study. Acta Dermato Venereol 52 [Suppl]
12. Kelly JP, Auquier A, Rzany B et al. (1995) An international collaborative case-control study of severe cutaneous adverse reactions (SCAR). Design and methods. J Clin Epidemiol 48:1099-1108
13. Lyell A (1956) Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br J Dermatol 68:355-361
14. Lyell A (1990) Requiem for toxic epidermal necrolysis. Br J Dermatol 122:837-846
15. Mockenhaupt M, Norgauer J (2002) Cutaneous adverse drug reactions. ACI International 14:143-149
16. Mockenhaupt M, Schlingmann J, Schröder W, Schöpf E (1998) Stevens-Johnson-Syndrom und Toxisch-epidermale Nekrolyse bei AIDS-Patienten: Inzidenz und Medikamentenanamnese. In: Garbe C, Rassner G (Hrsg) Dermatologie, Leitlinien und Qualitätssicherung für Diagnostik und Therapie. Springer, Berlin Heidelberg New York Tokyo
17. Mockenhaupt M, Schröder W, Schneck B et al. (1998) Populationsbezogene Erfassung von schweren Hautreaktionen in Deutschland. Allergo J 7:381-384
18. Mockenhaupt M, Viboud C, Roujeau JC et al. (2003) Severe cutaneous adverse reactions (SCAR): results on drug risks based on the EuroSCAR-study. Pharmacoepidemiol Drug Safety 12:147
19. Mockenhaupt M, Kelly JP, Kaufman D, Stern RS (2003) The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with nonsteroidal antiinflammatory drugs: a multinational perspective. J Rheumatol 30:2234-2240
20. Roujeau JC, Guillaume JC, Fabre JP et al. (1990) Toxic epidermal necrolysis (Lyell's syndrome): incidence and drug etiology in France, 1981-1985. Arch Dermatol 126:37-42
21. Roujeau JC, Bioulac-Sage P, Bourseau C et al. (1991) Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 127:1333
22. Roujeau JC, Kelly JP, Naldi L et al. (1995) Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis. N Eng J Med 333:1600-1607
23. Roujeau JC, Stern RS (1994) Severe adverse cutaneous reactions to drugs. N Eng J Med 331:1272-1285
24. Rzany B, Hering O, Mockenhaupt M et al. (1996) Histopathological and epidemiological characteristics of patients with erythema exsudativum multiforme majus (EEMM), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN). Br J Dermatol 135:6-11
25. Rzany B, Mockenhaupt M, Baur S et al. (1996) Epidemiology of erythema exsudativum multiforme majus (EEMM), Stevens-Johnsonsyndrome (SJS) and toxic epidermal necrolysis (TEN) in Germany (1990-1992). Structure and results of a population-based registry. J Clin Epidemiol 49:769-773
26. Salopek TG (1997) Nikolsky's sign: is it"wet"?. Br J Dermatol 136:762-767
27. Sassolas B, Halevy S, Bazin F et al. (2003) Acute generalized exanthematous pustulosis. Does it exist? J Invest Dermatol 121:1/0444
28. Schöpf E, Stühmer A, Rzany B et al. (1991) Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West-Germany. Arch Dermatol 127:839-842
29. Sidoroff A, Flahault A, Bouwes Bavinck JN et al. (2003) The spectrum of drugs that may cause acute generalized exanthematous pusulosis (AGEP) is different from the one for Stevens-Johnson syndrome or toxic epidermal necrolysis (TEN). J Invest Dermatol 121:1/0335
30. Sidoroff A, Halevy S, Bouwes Bavinck JN et al. (2001) Acute generalized exanthematous pustulosis (AGEP) - a clinical reaction pattern. J Cutan Pathol 28:113-119
31. Stern RS (2000) Improving the outcome of patients with toxic epidermal necrolysis and Stevens-Johnson syndrome. Arch Dermatol 136:410-411
32. Stevens AM, Johnson FC (1922) A new eruptive fever associated with stomatitis and ophthalmia: report of two cases in children. Am J Dis Child 24:526-533
33. Wilkins J, Morrison L, White CR (1992) Oculocutaneous manifestations of the erythema multiforme/ Stevens-Johnson/toxic epidermal necrolysis spectrum. Dermatol Clin 10:571